{"id":"NCT01072929","sponsor":"Cephalon","briefTitle":"A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder","officialTitle":"A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 and 200 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-01","primaryCompletion":"2012-03","completion":"2012-03","firstPosted":"2010-02-22","resultsPosted":"2015-01-26","lastUpdate":"2016-04-27"},"enrollment":433,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Depression"],"interventions":[{"type":"DRUG","name":"Armodafinil","otherNames":["Nuvigil","CEP-10953"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Armodafinil 150 mg/day","type":"EXPERIMENTAL"},{"label":"Armodafinil 200 mg/day","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The primary objective of the study is to determine whether armodafinil treatment, at a dosage of 150 mg/day, is more effective than placebo treatment as adjunctive therapy to mood stabilizers for treatment of adults with major depression associated with bipolar I disorder.","primaryOutcome":{"measure":"Change From Baseline to Week 8 in the Total Score From the 30-Item Inventory of Depressive Symptomatology-Clinician-Rated (IDS-C30)","timeFrame":"Day 0 (baseline), Week 8","effectByArm":[{"arm":"Placebo","deltaMin":-17.9,"sd":1.1},{"arm":"Armodafinil 150 mg/Day","deltaMin":-21.7,"sd":1.11},{"arm":"All Armodafinil","deltaMin":-20.8,"sd":1.07}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0097"},{"comp":"OG000 vs OG002","p":"0.0385"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":12,"exclusionCount":11},"locations":{"siteCount":40,"countries":["United States"]},"refs":{"pmids":["25099397"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":198},"commonTop":["Headache","Diarrhoea","Nausea","Insomnia","Feeling jittery"]}}